google-site-verification: googlef34d17771a9ef049.html Biologic Drug Delivery Technology | cba-consulting
  • LinkedIn Social Icon

© 2017 by Cambridge Biostrategy Associates LLC. Proudly created with Wix.com

Commercial Issue

Approach

Results

Thinking

New Formulation and Delivery Systems

for Biologic Drugs

A manufacturer seeking to acquire new drug-delivery technology. How large is the addressable market opportunity? How would the manufacturer monetize the technology capability? What business models are feasible?

Bioprocessing company seeking to extend their drug delivery capability through the acquisition of a new delivery technology wanted a third-party opinion on acquisition

In-depth interviews with industry experts, development of bottoms-up market model, and company analyses to understand the potential market and business models for the technology and path to market

  • Addressable market opportunity for the specific class of drug delivery

  • Industry feedback on the potential timing and competitive environment for drug delivery platform

  • New business model and capability assessment for market acceptance and success

Strategic evaluation of new drug delivery technologies

CASE STUDY